Next Article in Journal
Mucormycosis: Battle with the Deadly Enemy over a Five-Year Period in India
Previous Article in Journal
The Burden of Serious Fungal Infections in Cameroon
Previous Article in Special Issue
Patient Susceptibility to Candidiasis—A Potential for Adjunctive Immunotherapy
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessReview
J. Fungi 2018, 4(2), 45;

T2 Magnetic Resonance Assay: Overview of Available Data and Clinical Implications

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Rhode Island Hospital 593 Eddy Street, Providence, RI 02903, USA
Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI 02912, USA
Authors to whom correspondence should be addressed.
Received: 1 March 2018 / Revised: 31 March 2018 / Accepted: 2 April 2018 / Published: 4 April 2018
Full-Text   |   PDF [1132 KB, uploaded 3 May 2018]   |  


Invasive candidiasis is a common healthcare-associated infection with a high mortality rate that can exceed 60% in cases of septic shock. Blood culture performance is far from ideal, due to the long time to positivity and suppression by antifungal agents. The T2 Magnetic Resonance (T2MR) assay is an FDA-approved qualitative molecular diagnostic method that can detect and speciate the 5 most common Candida spp.; namely, Candida albicans, Candida glabrata, Candida parapsilosis, Candida tropicalis, and Candida krusei, in approximately 5 h. In a multicenter clinical trial that included both a prospective and a contrived arm to represent the full range of clinically relevant concentrations of Candida spp., T2MR demonstrated a sensitivity and specificity of 91.1% and 98.1%, respectively. The utility of T2MR in candidemia depends on the prevalence of disease in each clinical setting. In intensive care units and other high-prevalence settings, the incorporation of T2MR in diagnostic algorithms is very appealing. T2MR is expected to allow timely initiation of antifungal therapy and help with anti-fungal stewardship. In low-prevalence settings, the positive predictive value of T2MR might not be enough to justify initiation of antifungal treatment in itself. The performance of T2MR has not been studied in cases of deep-seated candidiasis. Despite some promising evidence in published clinical trials, further studies are needed to determine the performance of T2MR in invasive candidiasis without candidemia. Overall, experience with T2MR in everyday clinical practice is evolving but, in the right setting, this technology is expected to provide “actionable information” for the management of patients evaluated for candidemia. View Full-Text
Keywords: candidemia; invasive candidiasis; invasive fungal infections; T2MR; PCR; molecular diagnostics candidemia; invasive candidiasis; invasive fungal infections; T2MR; PCR; molecular diagnostics

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Zacharioudakis, I.M.; Zervou, F.N.; Mylonakis, E. T2 Magnetic Resonance Assay: Overview of Available Data and Clinical Implications. J. Fungi 2018, 4, 45.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
J. Fungi EISSN 2309-608X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top